COVID-19 and Pneumonia 3rd Edition
A special issue of Viruses (ISSN 1999-4915). This special issue belongs to the section "Coronaviruses".
Deadline for manuscript submissions: 31 December 2024 | Viewed by 126
Special Issue Editor
Interests: pulmonology; COVID-19 pneumonia; lung diseases
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Coronavirus disease 2019 (COVID-19) is an ongoing pandemic resulting from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), first isolated in December 2019 in Wuhan, China. Despite possible multisystem involvement, the lung is by far the most commonly affected organ in this disease.
COVID-19 pneumonia can present varying degrees of severity and respiratory deterioration. The spectrum of lung involvement ranges from mild flu-like cases to devastatingly rapid progression to respiratory distress, requiring intensive care support.
It is thus vital that we broaden our knowledge of the epidemiology, clinical manifestations, diagnosis, treatment, and evolution of this disease.
A better understanding of COVID-19 pneumonia could lead to significant improvements in medical treatment and outcomes for many patients.
We encourage the submission of articles and manuscripts that address this topic and continue advancing the scientific knowledge on COVID-19 pneumonia.
Dr. Javier de Miguel-Díez
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Viruses is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- COVID-19
- pneumonia
- lung diseases
- diagnosis
- treatment
- prognosis
